Tag:
Metamark Genetics
Latest Headlines
Latest Headlines
Metamark signs potential $365M deal with J&J unit
Metamark Genetics has entered an agreement with Janssen Biotech, a unit of Johnson & Johnson ( $JNJ ), to identify and characterize proprietary cancer targets that play a causal role in promoting
Metamark finds proteins that predict melanoma spread
Metamark Genetics made FierceBiomarkers' list of five prostate cancer diagnostics to watch , but the Cambridge, MA company recently reported progress in predicting whether early-stage primary melanoma
Cancer Dx company Metamark rounds up $22M
Cambridge, MA-based Metamark Genetics has raised $22 million in Series B funding. The cancer diagnostics firm's platform--called Metamark's Prognosis Determinans--allows physicians to identify which
Ventus raises $40M, names new CEO
Belmont, CA-based Ventus Medical has rounded up an impressive $40 million in Series D financing. Ventus plans to use to money to commercialize Provent Sleep Apnea Therapy, the company's prescription
